RDY offering history
Every offering-related filing in DR REDDYS LABORATORIES LTD’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,000 filings back to Feb 21, 2017.
| Date | Filing | What it means | |
|---|---|---|---|
| Oct 28, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
RDY offering FAQ
When did RDY last execute an offering?
No executed-offering document (424B pricing supplement or 8-K item 3.02) appears in the 1000 filings EDGAR returns for DR REDDYS LABORATORIES LTD, reviewed back to 2017-02-21.
When did RDY last announce or register an offering?
No offering registration (S-1/S-3/F-1/F-3) appears in the filings reviewed back to 2017-02-21.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.
Free to use. No account, no card.